GPT and metabolic dysfunction-associated steatotic liver disease: Given that NAFLD represents the hepatic component of the MetS;[5], [6] to be able to demonstrate the ALT-MetS relationship robustly with minimal bias, studies should sufficiently have long follow-up durations and steps should be taken to ensure that participants do not have prevalent NAFLD at baseline or other causes of elevated baseline levels of ALT should be excluded.